Sensitivity encoding for fast 1H MR spectroscopic imaging water reference acquisition
暂无分享,去创建一个
Theodoros N. Arvanitis | Andrew C Peet | Theodoros N Arvanitis | Martin Wilson | Martin Wilson | A. Peet | Rebecca Birch | Rebecca Birch
[1] J. Shih,et al. Proton magnetic resonance spectroscopy predicts survival in children with diffuse intrinsic pontine glioma , 2011, Journal of Neuro-Oncology.
[2] David Bonekamp,et al. Quantitative SENSE-MRSI of the human brain. , 2010, Magnetic resonance imaging.
[3] B D Ross,et al. Absolute Quantitation of Water and Metabolites in the Human Brain. I. Compartments and Water , 1993 .
[4] Filip Jiru,et al. Spectroscopic imaging: basic principles. , 2008, European journal of radiology.
[5] P Mansfield,et al. Spatial mapping of the chemical shift in NMR , 1983, Magnetic resonance in medicine.
[6] Theodoros N. Arvanitis,et al. Short echo time single voxel 1H magnetic resonance spectroscopy in the diagnosis and characterisation of pineal tumours in children , 2011, Pediatric blood & cancer.
[7] P. Boesiger,et al. SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.
[8] Gioacchino Tedeschi,et al. High Speed 1H Spectroscopic Imaging in Human Brain by Echo Planar Spatial‐Spectral Encoding , 1995, Magnetic resonance in medicine.
[9] D. Louis Collins,et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.
[10] Jens Frahm,et al. Clinical proton MR spectroscopy in central nervous system disorders. , 2013, Radiology.
[11] Sairam Geethanath,et al. Compressive sensing could accelerate 1H MR metabolic imaging in the clinic. , 2012, Radiology.
[12] Kiyohiro Houkin,et al. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. , 2004, Magnetic resonance imaging.
[13] Andrew C Peet,et al. MR spectroscopy-based brain metabolite profiling in propionic acidaemia: metabolic changes in the basal ganglia during acute decompensation and effect of liver transplantation , 2011, Orphanet journal of rare diseases.
[14] Theodoros N. Arvanitis,et al. Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours , 2013, European journal of cancer.
[15] Theodoros N. Arvanitis,et al. A constrained least‐squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data , 2011, Magnetic resonance in medicine.
[16] Theodoros N. Arvanitis,et al. Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS , 2008, NMR in biomedicine.
[17] G. Kendall,et al. Regional neonatal brain absolute thermometry by 1H MRS , 2013, NMR in biomedicine.
[18] Jens Frahm,et al. Use of phased array coils for a determination of absolute metabolite concentrations , 2005, Magnetic resonance in medicine.
[19] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[20] S F Keevil,et al. Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. , 1998, Magnetic resonance imaging.
[21] Gabriele Ende,et al. MR spectroscopy in Alzheimer’s disease: gender differences in probabilistic learning capacity , 2003, Neurobiology of Aging.
[22] P. Barker,et al. In vivo proton MR spectroscopy of the human brain , 2006 .
[23] P. Boesiger,et al. Trading spectral separation at 3T for acquisition speed in multi spin-echo spectroscopic imaging. , 2006, AJNR. American journal of neuroradiology.
[24] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[25] G B Matson,et al. Reduced phase encoding in spectroscopic imaging , 1994, Magnetic resonance in medicine.
[26] J R Griffiths,et al. Linear discriminant analysis of brain tumour 1H MR spectra: a comparison of classification using whole spectra versus metabolite quantification , 2007, NMR in biomedicine.
[27] Z P Liang,et al. A generalized series approach to MR spectroscopic imaging. , 1991, IEEE transactions on medical imaging.
[28] Sabine Van Huffel,et al. Reproducibility of rapid short echo time CSI at 3 tesla for clinical applications , 2013, Journal of magnetic resonance imaging : JMRI.
[29] Frederik Barkhof,et al. Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging , 2014, NMR in biomedicine.
[30] A. Sorensen,et al. Magnetic resonance as a cancer imaging biomarker. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Franklyn A Howe,et al. 1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.
[32] Theodoros N. Arvanitis,et al. The value of magnetic resonance spectroscopy in tumour imaging , 2008, Archives of Disease in Childhood.
[33] Michael D Noseworthy,et al. Intraindividual variability of striatal (1)H-MRS brain metabolite measurements at 3 T. , 2006, Magnetic resonance imaging.
[34] K P Pruessmann,et al. Sensitivity‐encoded spectroscopic imaging , 2001, Magnetic resonance in medicine.
[35] L. Astrakas,et al. Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors , 2004, Clinical Cancer Research.